The Effect of Age and Acetylator Phenotype on the Pharmacokinetics of Sulfasalazine in Patients with Rheumatoid Arthritis
Authors:
- 1 October 1992
- journal article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 23 (4) , 311-320
Abstract
The pharmacokinetic disposition of sulfasalazine and its metabolites was studied in 8 young and 12 elderly patients with active rheumatoid arthritis. Equal numbers of slow and fast acetylators were...Keywords
This publication has 21 references indexed in Scilit:
- Clinical Pharmacokinetic Considerations in the ElderlyClinical Pharmacokinetics, 1989
- Determination of salicylazosulphapyridine, sulphapyridine and its metabolites in serum and urineJournal of Pharmaceutical and Biomedical Analysis, 1986
- SULPHASALAZINE IN THE TREATMENT OF RHEUMATOID ARTHRITIS: RELATIONSHIP OF DOSE AND SERUM LEVELS TO EFFICACYRheumatology, 1985
- Clinical Pharmacokinetics of Sulphasalazine, Its Metabolites and Other Prodrugs of 5-Aminosalicylic AcidClinical Pharmacokinetics, 1985
- Sulphasalazine in rheumatoid arthritis: a double blind comparison of sulphasalazine with placebo and sodium aurothiomalate.BMJ, 1983
- Comparison between penicillamine and sulphasalazine in rheumatoid arthritis: Leeds-Birmingham trial.BMJ, 1983
- Distribution and metabolism in healthy volunteers of disodium azodisalicylate, a potential therapeutic agent for ulcerative colitis.Gut, 1982
- Clinical Pharmacokinetics of SulphasalazineClinical Pharmacokinetics, 1976
- The metabolism of salicylazosulphapyridine in ulcerative colitisGut, 1973
- An improved and simplified method of detecting the acetylator phenotype.Journal of Medical Genetics, 1969